Weekly Paclitaxel Plus Carboplatin in Preoperative Treatment of Breast Cancer
NCT01203267
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
108
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
Paclitaxel, Carboplatin
Sponsor
Shanghai Jiao Tong University School of Medicine
Collaborators
[object Object]
[object Object]